Ing Groep Nv Thermo Fisher Scientific Inc. Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ing Groep Nv holds 85,988 shares of TMO stock, worth $44.1 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

85,988

Previous 200,765 57.17%

Holding current value

$44.1 Million

Previous $111 Million 52.09%

% of portfolio

0.32%

Previous 0.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$531.86 - $624.21 $61 Million - $71.6 Million	-114,777 Reduced 57.17%	85,988 $53.2 Million
Q2 2024 Aug 13, 2024	BUY	$541.52 - $599.02 $60.9 Million - $67.4 Million	112,520 Added 127.51%	200,765 $111 Million
Q1 2024 May 10, 2024	SELL	$528.82 - $599.43 $66.9 Million - $75.9 Million	-126,550 Reduced 58.92%	88,245 $51.3 Million
Q4 2023 Feb 08, 2024	BUY	$431.41 - $532.94 $63.1 Million - $78 Million	146,342 Added 213.78%	214,795 $114 Million
Q3 2023 Oct 27, 2023	BUY	$498.29 - $574.41 $6.65 Million - $7.67 Million	13,353 Added 24.23%	68,453 $34.6 Million
Q2 2023 Aug 07, 2023	SELL	$508.46 - $591.13 $18.5 Million - $21.5 Million	-36,345 Reduced 39.75%	55,100 $28.7 Million
Q1 2023 May 09, 2023	BUY	$535.0 - $604.82 $4.69 Million - $5.3 Million	8,762 Added 10.6%	91,445 $52.7 Million
Q4 2022 Feb 10, 2023	BUY	$484.71 - $571.37 $10.3 Million - $12.2 Million	21,278 Added 34.65%	82,683 $45.5 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $6.22 Million - $7.41 Million	-12,260 Reduced 16.64%	61,405 $31.1 Million
Q2 2022 Aug 08, 2022	SELL	$500.9 - $612.21 $15 Million - $18.3 Million	-29,853 Reduced 28.84%	73,665 $40 Million
Q1 2022 May 13, 2022	BUY	$524.0 - $644.92 $27.3 Million - $33.6 Million	52,087 Added 101.28%	103,518 $61.1 Million
Q4 2021 Feb 11, 2022	BUY	$569.0 - $667.24 $10.5 Million - $12.3 Million	18,402 Added 55.71%	51,431 $34.3 Million
Q3 2021 Nov 02, 2021	BUY	$509.53 - $609.78 $381,637 - $456,725	749 Added 2.32%	33,029 $18.9 Million
Q2 2021 Aug 13, 2021	BUY	$441.0 - $508.24 $2.74 Million - $3.15 Million	6,207 Added 23.81%	32,280 $16.3 Million
Q1 2021 May 12, 2021	SELL	$439.85 - $518.83 $94,567 - $111,548	-215 Reduced 0.82%	26,073 $11.9 Million
Q4 2020 Feb 11, 2021	BUY	$435.06 - $527.66 $7.63 Million - $9.25 Million	17,533 Added 200.26%	26,288 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$359.77 - $441.52 $1.95 Million - $2.39 Million	5,414 Added 162.05%	8,755 $3.87 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $1.1 Million - $1.45 Million	-3,996 Reduced 54.46%	3,341 $1.21 Million
Q1 2020 May 06, 2020	BUY	$255.3 - $340.05 $1.87 Million - $2.49 Million	7,337 New	7,337 $2.08 Million
Q4 2019 Feb 10, 2020	SELL	$271.93 - $328.04 $541,956 - $653,783	-1,993 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$268.46 - $305.43 $15.5 Million - $17.7 Million	-57,830 Reduced 96.67%	1,993 $581,000
Q2 2019 Aug 12, 2019	SELL	$257.51 - $295.55 $35,278 - $40,490	-137 Reduced 0.23%	59,823 $17.6 Million
Q1 2019 May 13, 2019	BUY	$212.17 - $273.72 $11.1 Million - $14.4 Million	52,534 Added 707.43%	59,960 $16.4 Million
Q4 2018 Feb 13, 2019	BUY	$208.47 - $251.98 $823,039 - $994,817	3,948 Added 113.51%	7,426 $1.66 Million
Q3 2018 Nov 06, 2018	SELL	$205.57 - $244.32 $1.15 Million - $1.37 Million	-5,602 Reduced 61.7%	3,478 $849,000
Q2 2018 Aug 10, 2018	BUY	$203.14 - $219.53 $1.39 Million - $1.5 Million	6,828 Added 303.2%	9,080 $1.88 Million
Q1 2018 May 07, 2018	BUY	$192.98 - $224.11 $434,590 - $504,695	2,252 New	2,252 $465,000
Q4 2017 Feb 06, 2018	SELL	$182.03 - $200.37 $1.3 Million - $1.43 Million	-7,147 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$171.74 - $194.04 $1.23 Million - $1.39 Million	7,147	7,147 $1.35 Million

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account